Human Metabolome Technologies, Inc. reported consolidated earnings results for the second quarter ended September 2018. For the quarter, the company reported net sales of ¥276 million against ¥307 million a year ago. Operating loss was ¥293 million against ¥228 million a year ago. Ordinary loss was ¥287 million against ¥227 million a year ago. Loss attributable to owners of parent was ¥288 million against ¥227 million a year ago. Basic earnings per share were ¥49.42 against ¥39.20 a year ago.

For the year ending March 2019, the company expects net sales of ¥1,100 million, operating loss of ¥285 million, ordinary loss of ¥285 million, loss attributable to owners of parent of ¥295 million and basic loss per share of ¥50.59.